NCT07527468 2026-04-14
HISMAR
Hôpital du Valais
Phase NA Not yet recruiting
Clinical Trials
45 trialsNCT05931302 2026-04-13
GALILEE
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Phase NA Active not recruiting
NCT06067503 2026-04-13
Biomarkers to Detect Endocrine Therapy Resistance
University of Wisconsin, Madison
Phase 2 Recruiting
NCT05837767 2026-03-30
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT07432633 2026-03-27
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Blue Earth Diagnostics
Phase 1/2 Recruiting
NCT07020806 2026-03-23
[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)
University of California, Davis
Phase 1 Recruiting
NCT00616967 2026-03-05
Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Active not recruiting
NCT03414970 2026-02-24
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Active not recruiting
NCT01953588 2026-01-22
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
Alliance for Clinical Trials in Oncology
Phase 3 Active not recruiting
NCT07313033 2026-01-16
FAPI-CL
Hospices Civils de Lyon
Phase NA Not yet recruiting
NCT06408168 2026-01-05
Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial)
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT03620643 2025-10-30
ROLo
Royal Marsden NHS Foundation Trust
Phase 2 Completed
NCT00295893 2025-09-25
Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer
City of Hope Medical Center
Phase 2 Active not recruiting
NCT05919108 2025-09-09
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
Vanderbilt-Ingram Cancer Center
Phase 2 Recruiting
NCT01819233 2025-06-06
CAREFOR
Thomas Jefferson University
Phase NA Completed
NCT04252859 2025-05-18
[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma
University of Utah
Phase 2 Terminated
NCT02764541 2025-05-07
Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)
Dana-Farber Cancer Institute
Phase 2 Active not recruiting
NCT04750473 2025-01-17
Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer
Emory University
Phase 1 Completed
NCT05982496 2024-12-10
FESTA
Università Vita-Salute San Raffaele
Phase NA Not yet recruiting
NCT04551495 2024-12-04
ROSALINE
Jules Bordet Institute
Phase 2 Active not recruiting
NCT05960201 2024-08-21
Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular Carcinoma
Asan Medical Center
Phase 2 Completed
NCT00909909 2023-08-03
Radiation Therapy in Treating Women With Early Stage Breast Cancer
Rutgers, The State University of New Jersey
Phase 2 Active not recruiting
NCT01417286 2023-04-20
Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer
Rutgers, The State University of New Jersey
Phase 2 Completed
NCT00433589 2022-11-17
MINDACT
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT01082211 2022-06-21
Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
Radiation Therapy Oncology Group
Phase 2 Completed
NCT01688388 2022-05-11
Single Fraction Intraoperative Radiotherapy
St. Joseph Hospital of Orange
Phase NA Completed
NCT02137252 2021-11-16
Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer
Dana-Farber Cancer Institute
Phase 2 Terminated
NCT03834532 2021-11-02
Living Well After Breast Surgery
University of Texas at Austin
Phase NA Completed
NCT01796041 2021-01-28
ICG
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Completed
NCT00599989 2020-04-09
Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT01753908 2019-10-31
Broccoli Sprout Extract in Treating Patients With Breast Cancer
Roswell Park Cancer Institute
Phase EARLY_PHASE1 Completed
NCT00058058 2019-07-16
ACRIN-6667
American College of Radiology Imaging Network
Phase NA Completed
NCT00096343 2018-12-04
Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer
University of Alabama at Birmingham
Phase 2 Completed
NCT00182793 2017-02-23
Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
City of Hope Medical Center
Phase 2 Completed
NCT00044291 2015-07-31
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Intarcia Therapeutics
Phase 3 Completed
NCT00960336 2014-10-29
Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast Cancer
ARCAGY/ GINECO GROUP
Phase 2 Completed
NCT00301041 2013-08-21
Radiation Therapy in Treating Women With Invasive Breast Cancer
University of California, San Francisco
Phase EARLY_PHASE1 Completed
NCT00304096 2013-04-09
Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
University of Virginia
Phase 1 Completed
NCT01055678 2012-12-17
To Evaluate the Characteristics of a Breast Cancer
Duke University
Phase EARLY_PHASE1 Withdrawn
NCT01641406 2012-07-16
NACprotocol
Auxilio Mutuo Cancer Center
Phase 2 Unknown
NCT01038258 2012-07-13
PETBreast
Auxilio Mutuo Cancer Center
Phase NA Unknown
NCT01100489 2011-12-08
Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer
Case Comprehensive Cancer Center
Phase 2 Withdrawn
NCT00084669 2010-04-28
Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer
Massachusetts General Hospital
Phase NA Completed
NCT00267553 2007-09-10
Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer
Intarcia Therapeutics
Phase 3 Terminated
NCT00097344 2007-08-23
The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Intarcia Therapeutics
Phase 3 Terminated